These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18193168)

  • 21. Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation.
    Nagabhushana A; Bansal M; Swarup G
    PLoS One; 2011 Mar; 6(3):e17477. PubMed ID: 21408173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.
    Liu S; Lv J; Han L; Ichikawa T; Wang W; Li S; Wang XL; Tang D; Cui T
    Biochem Biophys Res Commun; 2012 Mar; 420(1):78-83. PubMed ID: 22406061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.
    Tauriello DV; Haegebarth A; Kuper I; Edelmann MJ; Henraat M; Canninga-van Dijk MR; Kessler BM; Clevers H; Maurice MM
    Mol Cell; 2010 Mar; 37(5):607-19. PubMed ID: 20227366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research progress of deubiquitinating enzyme CYLD to regulate liver-related diseases].
    Yang X; An DJ; Gao CC; Qin HY
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):477-480. PubMed ID: 31357769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutated cylindromatosis gene affects the functional state of dendritic cells.
    Bros M; Dexheimer N; Besche V; Masri J; Trojandt S; Hövelmeyer N; Reissig S; Massoumi R; Grabbe S; Waisman A; Reske-Kunz AB
    Eur J Immunol; 2010 Oct; 40(10):2848-57. PubMed ID: 20836156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CYLD and NF-kappaB in human cholesteatoma epithelium.
    Byun JY; Yune TY; Lee JY; Yeo SG; Park MS
    Mediators Inflamm; 2010; 2010():796315. PubMed ID: 20414373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
    Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
    J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.
    Brummelkamp TR; Nijman SM; Dirac AM; Bernards R
    Nature; 2003 Aug; 424(6950):797-801. PubMed ID: 12917690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner.
    Tsagaratou A; Trompouki E; Grammenoudi S; Kontoyiannis DL; Mosialos G
    J Immunol; 2010 Aug; 185(4):2032-43. PubMed ID: 20644164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenoviral vector expressing CYLD augments antitumor activity of TRAIL by suppression of NF-kappaB survival signaling in hepatocellular carcinoma.
    Chu L; Gu J; He Z; Xiao T; Liu X
    Cancer Biol Ther; 2006 Jun; 5(6):615-22. PubMed ID: 16627981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [CYLD deubiquitinase as a recurrent target in oncogenic processes].
    Bonnet M; Courtois G
    Med Sci (Paris); 2011; 27(6-7):626-31. PubMed ID: 21718647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential role of CYLD (Cylindromatosis) as a deubiquitinating enzyme in vascular cells.
    Takami Y; Nakagami H; Morishita R; Katsuya T; Hayashi H; Mori M; Koriyama H; Baba Y; Yasuda O; Rakugi H; Ogihara T; Kaneda Y
    Am J Pathol; 2008 Mar; 172(3):818-29. PubMed ID: 18245814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels.
    Miliani de Marval P; Lutfeali S; Jin JY; Leshin B; Selim MA; Zhang JY
    Cancer Prev Res (Phila); 2011 Jun; 4(6):851-9. PubMed ID: 21478324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.
    Schlicher L; Wissler M; Preiss F; Brauns-Schubert P; Jakob C; Dumit V; Borner C; Dengjel J; Maurer U
    EMBO Rep; 2016 Oct; 17(10):1485-1497. PubMed ID: 27458237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of CYLD might be associated with development of salivary gland tumors.
    Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
    Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of optineurin as an interleukin-1 receptor-associated kinase 1-binding protein and its role in regulation of MyD88-dependent signaling.
    Tanishima M; Takashima S; Honda A; Yasuda D; Tanikawa T; Ishii S; MaruYama T
    J Biol Chem; 2017 Oct; 292(42):17250-17257. PubMed ID: 28882891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma.
    Saito K; Kigawa T; Koshiba S; Sato K; Matsuo Y; Sakamoto A; Takagi T; Shirouzu M; Yabuki T; Nunokawa E; Seki E; Matsuda T; Aoki M; Miyata Y; Hirakawa N; Inoue M; Terada T; Nagase T; Kikuno R; Nakayama M; Ohara O; Tanaka A; Yokoyama S
    Structure; 2004 Sep; 12(9):1719-28. PubMed ID: 15341735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of CYLD, NF-kappaB and NF-kappaB-related factors in salivary gland tumors.
    Fukuda M; Fukuda F; Horiuchi Y; Oku Y; Suzuki S; Kusama K; Sakashita H
    In Vivo; 2006; 20(4):467-72. PubMed ID: 16900776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of NF-κB by deubiquitinases.
    Harhaj EW; Dixit VM
    Immunol Rev; 2012 Mar; 246(1):107-24. PubMed ID: 22435550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.
    Blake PW; Toro JR
    Hum Mutat; 2009 Jul; 30(7):1025-36. PubMed ID: 19462465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.